drugset / Trial / NCT04297618
The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study to evaluate changes in comfort and dryness in symptomatic contact lens (CL) wearers after using Xiidra (lifitegrast 5.0% ophthalmic solution) for 12 weeks.
Timeline
- Start
- 2021-07-07
- Primary completion
- 2024-04-18
- Completion
- 2024-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lifitegrast | Unknown | 5 % | Other |